MLLT3
MLLT3, also known as AF-9, AF9 or YEATS3, is a nuclear chromatin reader and a component of the super elongation complex. It recognises acylated histone H3, particularly crotonylated H3, and helps maintain haematopoietic stem cell stemness. Browse Assay Genie's current range of MLLT3 research reagents below, or read on for the biology behind the target.
MLLT3 is a chromatin reader subunit of the super elongation complex (SEC). The SEC increases the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Within the complex, MLLT3 recruits the SEC to modified histones. It binds acylated histone H3 and prefers crotonylated H3, recognising H3K9cr and, with slightly lower affinity, H3K18cr. It also binds H3K9ac and H3K9bu, but with lower affinity than the crotonylated mark. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors.
Recruitment of the SEC to crotonylated histones promotes recruitment of DOT1L to active chromatin, where it deposits H3K79 methylation. In haematopoietic stem cells (HSCs), MLLT3 binds the transcription start site of active genes and sustains H3K79me2, probably by recruiting DOT1L. This preserves, rather than confers, HSC stemness. MLLT3 is also required for DOT1L-mediated H3K79 hypermethylation at the SCNN1A promoter, which results in transcriptional repression, and it may play a role in leukemogenic gene transcription. According to NCBI Gene, the MLLT3 gene is involved in HSC differentiation, regulation of stem cell division and positive regulation of DNA-templated transcription. It also acts upstream of or within negative regulation of canonical Wnt signalling and positive regulation of the planar cell polarity Wnt pathway.
The MLLT3 protein is located in the nucleoplasm and on chromosomes, and is part of the transcription elongation factor complex. HGNC places it in the super elongation complex and YEATS domain containing gene groups, and lists it among microRNA protein coding host genes. Its previous names, myeloid/lymphoid or mixed-lineage leukaemia; translocated to, 3, reflect its origin in leukaemia research. The mouse ortholog is Mllt3.
MLLT3 reads crotonylated, acetylated and butyrylated histone H3, making it a model for studying how acyl marks on active promoters and enhancers are interpreted.
As a super elongation complex subunit, MLLT3 helps suppress RNA polymerase II pausing and recruits the complex to crotonylated chromatin.
MLLT3 preserves HSC stemness by binding active transcription start sites and sustaining H3K79me2, probably through DOT1L recruitment.
MLLT3 may contribute to leukemogenic gene transcription, and its gene name derives from mixed-lineage leukaemia translocation studies.
MLLT3 is a chromatin reader in the super elongation complex. It binds acylated histone H3, preferring crotonylated H3, and recruits the complex to active chromatin. This promotes DOT1L recruitment and H3K79 methylation, and supports transcription elongation by RNA polymerase II.
MLLT3 is also called AF-9, AF9 and YEATS3, and UniProt names the protein Protein AF-9. Earlier names were myeloid/lymphoid or mixed-lineage leukaemia; translocated to, 3. The HGNC full name is MLLT3 super elongation complex subunit.
UniProt reports that MLLT3 maintains haematopoietic stem cell stemness by sustaining H3K79me2 at active genes, and that it may play a role in leukemogenic gene transcription. Its name reflects its identification in mixed-lineage leukaemia translocations. The mouse ortholog is Mllt3.
Related chromatin regulators and leukaemia-associated targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P42568; product specifications from Assay Genie datasheets.